Fireside chat: Building a viable commercial model in CGT

As CGT products reach the market, companies face pressure to demonstrate value, ensure patient access, and maintain financial sustainability. Traditional biopharma models often do not fit the unique cost structures and distribution challenges of CGT. This panel brings together experts to discuss how commercial models can evolve to meet the needs of patients, payers, and investors. 

Key takeaways: 

• Evaluate pricing and reimbursement strategies tailored to CGT products. 

• Explore approaches for aligning payer expectations with long-term clinical benefit. 

• Assess distribution and supply chain considerations for scaling CGT. 

• Identify risk-sharing and value-based models that improve affordability and access. 

• Discuss how commercial frameworks can adapt to regulatory and market dynamics.